![Shu Kam Mok](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 906 485 $ al 31/08/2026
Shu Kam Mok was the founder of Sanomics Ltd. founded in 2015, holding the title of Chairman.
Dr. Mok is also the founder of Chinese Thoracic Oncology Group,Asia Thoracic Oncology Research Group,Aurora Tele-Oncology Ltd...
Dr. Mok currently serves as Independent Non-Executive Director at AstraZeneca PLC since 2019, Non-Executive Independent Director at Lunit Usa, Inc., Director at Insighta Ltd., and Secretary at the Chinese Society of Clinical Oncology.
Former positions include Chairman-Clinical Oncology Department at The Chinese University of Hong Kong, Chairman at ACT Genomics Co. Ltd., Lead Independent Non-Executive Director at HUTCHMED (China) Ltd. from 2025 to 2026, Director at American Society of Clinical Oncology, Inc., and Treasurer at the International Association for the Study of Lung Cancer.
Education includes undergraduate and doctorate degrees from the University of Alberta.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2025 | 3.500 ( 0 % ) | 568 704 $ | 31/08/2026 | |
HUTCHMED (CHINA) LIMITED 0,02 % | 12/05/2026 | 136.705 ( 0,02 % ) | 337 782 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ASTRAZENECA PLC | Director/Miembro de la Junta | 01/01/2019 |
Chinese Society of Clinical Oncology | Secretario Corporativo | - |
Lunit Usa, Inc. | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| HUTCHMED (CHINA) LIMITED | Director/Miembro de la Junta | 12/05/2026 |
ACT Genomics Co. Ltd.
 ACT Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services Provides cancer solutions | Presidente | 01/01/2022 |
Aurora Tele-Oncology Ltd.
 Aurora Tele-Oncology Ltd. Medical/Nursing ServicesHealth Services Operates an oncology-specific teleconsultation platform striving to improve cancer care | Fundador | - |
Chinese Thoracic Oncology Group | Fundador | - |
Asia Thoracic Oncology Research Group | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 13 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
HUTCHMED (China) Ltd.
 HUTCHMED (China) Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products | Health Technology |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Chinese University of Hong Kong
 The Chinese University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
International Association for the Study of Lung Cancer
 International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a multidisciplinary organization dedicated to the study, research, and eradication of lung cancer and other thoracic malignancies. The non-profit company is based in Aurora, CO. It serves a diverse community including oncologists, thoracic specialists, scientists, patient advocates, and caregivers, advancing lung cancer care through collaborative science, education, advocacy, and clinical practice. IASLC organizes major conferences, supports scientific projects, develops resources for targeted therapy, and publishes journals focused on thoracic oncology. The organization fosters professional development, provides educational materials, policy toolkits, patient advocacy initiatives, and training workshops to improve lung cancer diagnosis, treatment, and prevention. | Commercial Services |
ACT Genomics Co. Ltd.
ACT Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services Provides cancer solutions | Health Services |
Chinese Society of Clinical Oncology | |
Sanomics Ltd.
 Sanomics Ltd. Miscellaneous Commercial ServicesCommercial Services Specializes in blood-based genomics technologies for cancer patients | Commercial Services |
Chinese Thoracic Oncology Group | |
Asia Thoracic Oncology Research Group | |
Aurora Tele-Oncology Ltd.
Aurora Tele-Oncology Ltd. Medical/Nursing ServicesHealth Services Operates an oncology-specific teleconsultation platform striving to improve cancer care | Health Services |
Lunit Usa, Inc. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
